US UGM program announced: Platform migration, cloud and discovery

news · 7 years ago
Presenting institutions include: Boehringer Ingelheim, BMS, Broad Inst, DOW, Eli Lilly, GSK, NIH, Novartis, Pearson, Takeda and Wiley. Major threads include platform migration, cloud deployment, integrating and extending capabilities for discovery chemistry.

Complete program.

Summary from Wendy Warr's 2011 US UGM Meeting report If you were hoping for the usual short report, I apologise. This time there was so much happening that I feel that more detail is justified. I could not help comparing this event to the dozens of MDL user meetings I attended in various countries in the 1980s and 1990s. Ongoing themes at the ChemAxon meeting included the guy with his list of 40 most wanted enhancements, Yet Another Registration System, some of the same old faces, useful gossip, and so on. Admittedly, the dress code is smart casual rather than three-piece suits and earrings (not combined!), and there are more Hungarian speakers than German speakers at the European event, but the elements of déja vu are there. In the 1980s we used to have the “3D day” at the MDL User group meeting: half a dozen enthusiasts would attend and the rest of the delegates took a day off sightseeing in San Francisco. ChemAxon users are not afraid of computational chemistry and 3D. I never went to many Daylight meetings but I suggest that the ChemAxon user meeting is also a cross between a MUG and an MDL meeting. At least one of the two annual ChemAxon user meetings is now an essential date in my calendar and the dates are blocked out a year in advance. I say all this in order to give readers an idea of the significance that ChemAxon is achieving in the cheminformatics arena. I strongly recommend that you keep an eye on this company.

Useful links:

Program: More information: Registration: One to One & One to Many Sessions: Developer Training: End user training details: UGM archives - slides and video and meeting reports from Wendy Warr and Yvonne Martin: